These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15560172)
1. [Present-day hypotheses of prostatic cancer etiology and pathogenesis]. Gubanov ES; Prianichkova MB Urologiia; 2004; (5):72-6. PubMed ID: 15560172 [No Abstract] [Full Text] [Related]
2. The role of testosterone in the pathogenesis of prostate cancer. Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Nihei N; Naya Y; Ichikawa T Int J Urol; 2008 Jun; 15(6):472-80. PubMed ID: 18430151 [TBL] [Abstract][Full Text] [Related]
3. What is the role of inflammation in the pathogenesis of prostate cancer? Goldstraw MA; Fitzpatrick JM; Kirby RS BJU Int; 2007 May; 99(5):966-8. PubMed ID: 17437426 [No Abstract] [Full Text] [Related]
4. [Chronic prostatitis--risk factor in development of prostatic cancer (review)]. Mazo EB; Kozdoba AS Ter Arkh; 2007; 79(10):66-73. PubMed ID: 18154149 [No Abstract] [Full Text] [Related]
5. [Pathogenesis of cancer of the prostate gland]. Gasparian AM; Portnoĭ AS Urol Nefrol (Mosk); 1970; 35(4):49-53. PubMed ID: 5484277 [No Abstract] [Full Text] [Related]
6. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer]. Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351 [No Abstract] [Full Text] [Related]
7. Piezoelectricity and prostate cancer: proposed interaction between electromagnetic field and prostatic crystalloids. Ghabili K; Shoja MM; Agutter PS Cell Biol Int; 2008 Jun; 32(6):688-91. PubMed ID: 18299212 [TBL] [Abstract][Full Text] [Related]
8. Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer. Merseburger AS; Kramer MW; Hennenlotter J; Simon P; Knapp J; Hartmann JT; Stenzl A; Serth J; Kuczyk MA Prostate; 2008 Jan; 68(1):72-7. PubMed ID: 18008332 [TBL] [Abstract][Full Text] [Related]
9. Estrogens and aspects of prostate disease. Prezioso D; Denis LJ; Klocker H; Sciarra A; Reis M; Naber K; Lobel B; Pacik D; Griffiths K Int J Urol; 2007 Jan; 14(1):1-16. PubMed ID: 17199853 [TBL] [Abstract][Full Text] [Related]
10. Inflammation in the etiology of prostate cancer: an epidemiologic perspective. Sutcliffe S; Platz EA Urol Oncol; 2007; 25(3):242-9. PubMed ID: 17483023 [TBL] [Abstract][Full Text] [Related]
11. Obesity and prostate cancer: importance of race and stage of disease. Freedland SJ J Urol; 2007 Nov; 178(5):1842-3. PubMed ID: 17868740 [No Abstract] [Full Text] [Related]
15. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate. Zhigang Z; Wenlu S Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024 [TBL] [Abstract][Full Text] [Related]
16. The development of prostate cancer despite late onset androgen deficiency. Sengupta S; Duncan HJ; Macgregor RJ; Russell JM Int J Urol; 2005 Sep; 12(9):847-8. PubMed ID: 16201985 [TBL] [Abstract][Full Text] [Related]
17. Assessing risk: does this patient have prostate cancer? Carter HB J Natl Cancer Inst; 2006 Apr; 98(8):506-7. PubMed ID: 16622114 [No Abstract] [Full Text] [Related]
18. An unusual case of concurrent breast and prostate cancer. Woo TC; Choo R; Chander S Can J Urol; 2004 Oct; 11(5):2390-2. PubMed ID: 15576004 [TBL] [Abstract][Full Text] [Related]
19. The role of inflammation and infection in the pathogenesis of prostate carcinoma. Wagenlehner FM; Elkahwaji JE; Algaba F; Bjerklund-Johansen T; Naber KG; Hartung R; Weidner W BJU Int; 2007 Oct; 100(4):733-7. PubMed ID: 17662075 [TBL] [Abstract][Full Text] [Related]
20. Hypertriglyceridemia as a possible risk factor for prostate cancer. Wuermli L; Joerger M; Henz S; Schmid HP; Riesen WF; Thomas G; Krek W; Cerny T; Gillessen S Prostate Cancer Prostatic Dis; 2005; 8(4):316-20. PubMed ID: 16158078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]